Emc Capital Management Biolife Solutions Inc Transaction History

Emc Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$32.99 - $58.55 $721,755 - $1.28 Million	-21,878 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$29.51 - $44.62 $106,944 - $161,702	-3,624 Reduced 14.21%	21,878 $974,000
Q1 2021 May 05, 2021	SELL	$32.95 - $44.24 $219,875 - $295,213	-6,673 Reduced 20.74%	25,502 $918,000
Q4 2020 Feb 24, 2021	BUY	$27.5 - $45.75 $884,812 - $1.47 Million	32,175 New	32,175 $1.28 Million

188

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.12B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.